Britain | Chronic problems

Britain’s stringent rules on medical cannabis harm patients

But the country is still a big (legal) producer of the green stuff

Climbing high

SATIVEX comes in a small brown glass vial. Each spray, delivered under the tongue or to the cheek, emits 100 microlitres of a solution including alcohol, peppermint oil and a mixture of THC and CBD, the active ingredients in cannabis. GW Pharmaceuticals, its manufacturer, insists it is a “cannabis-based medicine”, not “medical marijuana”, since it is made to exacting pharmaceutical standards. It nevertheless contains extracts from Cannabis sativa, the cannabis flower and plant, and some users report a mild high. It can be prescribed by doctors, most often to sufferers from multiple sclerosis (MS).

This article appeared in the Britain section of the print edition under the headline “Chronic problems”

The battle for digital supremacy

From the March 17th 2018 edition

Discover stories from this section and more in the list of contents

Explore the edition
Britain's King Charles III (C-L) and Britain's Catherine, Princess of Wales (C-R) speak with Second World War veterans during a tea party at Buckingham Palace

Britain’s second-world-war veterans are dying out

The country celebrates the last big anniversary with the generation that beat Hitler

offshore wind turbines and oil tankers in Aberdeen

Aberdeen shows why the UK’s clean-energy transition will be messy

The jobs in renewables can’t come fast enough to replace those related to oil and gas


Winter sun highlights the church steeple

The Church of England is dying out and selling up

Even if you don’t go to church, this matters


Young British men are turning to Catholicism in surprising numbers

It offers bells, smells—and certainty

Nigel Farage’s economic plans are a disaster

Three choices: fiscal implosion, deep austerity or a hasty U-turn

The Britain-India trade deal is a sign of things to come

American tariffs are likely to accelerate bilateral trade deals